Jim Faulkner
Chief Technical Advisor
Cell and Gene Therapy CatapultLondon, England, United Kingdom
3 investmentsJim Faulkner is a Chief Technical Advisor at Cell and Gene Therapy Catapult based in London, England, United Kingdom. Jim Faulkner has backed 3 companies, including Ascidian Therapeutics, GlaxoSmithKline and Vitarka Therapeutics. Investment focus areas include Biotech, Biotechnology and UK-based Startups.
Sign up to access email, LinkedIn & portfolio
Investment Focus
Access Full Contact Information
Get Jim Faulkner's email, LinkedIn, Twitter, full portfolio of investments, and export data to CSV.
Email
LinkedIn
Portfolio
3-day free trial, cancel anytime
Raising a round? Run your numbers first
Free tools founders use before pitching investors like this one.